Advertisement
Screener

Adial Pharmaceuticals, Inc. (ADIL) Charity Care, Reimbursements Received

1.7 / 5 stars · 15/45 Roast Me

Adial Pharmaceuticals, Inc. Charity Care, Reimbursements Received

Adial Pharmaceuticals, Inc. (ADIL) reported Charity Care, Reimbursements Received of $350.00 thousand for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.

Discontinued › Notes

us-gaap:CharityCareReimbursementsReceived · last filed 2023-11-14

  • Adial Pharmaceuticals, Inc. charity care, reimbursements received for the quarter ending 2023-09-30 was -$387.28K.
Period endCharity Care, Reimbursements Received 3 monthCharity Care, Reimbursements Received 6 monthCharity Care, Reimbursements Received 9 month
2023-09-30-$387.28K
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2023-11-14
$350.00K
10-Q · filed 2023-11-14
2023-06-30$737.28K
10-Q/A · filed 2023-10-30
2018-06-30$38.25K
10-Q · filed 2018-09-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Phio Pharmaceuticals Corp. (PHIO)United States$0.012B-0.92
Scienture Holdings, Inc. (SCNX)United States$0.012B-0.38
KIORA PHARMACEUTICALS INC (KPRX)United States$0.012B
BIOVIE INC. (BIVI)United States$0.012B
Dare Bioscience, Inc. (DARE)United States$0.011B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
Tempest Therapeutics, Inc. (TPST)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
Moleculin Biotech, Inc. (MBRX)United States$0.011B
MetaVia Inc. (MTVA)United States$0.011B-0.65